Details for New Drug Application (NDA): 077130
✉ Email this page to a colleague
The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for 077130
Tradename: | RIVASTIGMINE TARTRATE |
Applicant: | Dr Reddys Labs Inc |
Ingredient: | rivastigmine tartrate |
Patents: | 0 |
Pharmacology for NDA: 077130
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 077130
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 077130 | ANDA | Dr. Reddy's Laboratories Limited | 55111-352 | 55111-352-01 | 100 CAPSULE in 1 BOTTLE (55111-352-01) |
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 077130 | ANDA | Dr. Reddy's Laboratories Limited | 55111-352 | 55111-352-05 | 500 CAPSULE in 1 BOTTLE (55111-352-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1.5MG BASE | ||||
Approval Date: | Oct 31, 2007 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 3MG BASE | ||||
Approval Date: | Oct 31, 2007 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 4.5MG BASE | ||||
Approval Date: | Oct 31, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription